Delivery Order SPE2DB22D3102-SPE2DB24FL1NL

Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Levothyroxine 137 MCG Tablets in 1,000-count quantities, with a ceiling value of $1,617.60 and a performance period through October 31, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 microgram tablets of the drug levothyroxine. The contract has a ceiling value of $3,997.05 and runs through January 3, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order with a firm fixed price valued at $1,167.18, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of 4,565,749,812 units of Levothyroxine 50 MCG Tablets, a medication used to treat hypothyroidism. The ultimate completion date for this delivery order is September 11, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $1,242.71 and is for the delivery of 4,563,017,653 units of the prescription drug Levothyroxine 50 MCG Tablet. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant...
The Defense Logistics Agency (DLA) awarded a $1,092.69 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,563,189,790 units of 112 mcg Levothyroxine tablets. This contract, with an ultimate completion date of December 28, 2023, is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying a wide range of medical products, including specialty medications,...
This federal contract award, valued at $8,598.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the drug Levothyroxine 125 mcg tablets, a medication used to treat thyroid disorders. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) for the supply of 4,566,076 vials of 500 mcg Levothyroxine, a thyroid medication. The contract is a firm-fixed price arrangement with a ceiling value of $6,825.18 and an ultimate completion date of October 11, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,671.28, is for the delivery of 4,565,021,765 units of the drug Synthroid (levothyroxine sodium) 137 mcg tablets. The contract has a ceiling value of $13,671.28 and runs through June 28, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999 that serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Levothyroxine 25 mcg capsules. The contract has a ceiling value of $1,230.19 and is set to run through August 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,165 units of the medication Synthroid (levothyroxine sodium) in 25 mcg tablets. The contract has a ceiling value of $1,106.36 and runs from October 21, 2024 to October 22, 2024. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB24FL1NL
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,271.02, is for the delivery of 4,564,817,264 units of Levothyroxine 137 MCG Tablets in 1,000 count bottles. The contract has a completion date of June 6, 2024 and uses a Firm Fixed Price pricing structure.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is a delivery order issued against this larger IDC. No set-aside designation was used for this contract.

Generated 5/16/25, 12:00 PM